CCDC175

gene
On this page

Summary

CCDC175 (coiled-coil domain containing 175, HGNC:19847) is a protein-coding gene on chromosome 14q23.1, encoding Coiled-coil domain-containing protein 175 (P0C221).

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 102 total
  • MANE Select transcript: NM_001164399

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19847
Approved symbolCCDC175
Namecoiled-coil domain containing 175
Location14q23.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000151838
Ensembl biotypeprotein_coding
Entrez729665

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 3 protein_coding_CDS_not_defined, 2 protein_coding

ENST00000281581, ENST00000537690, ENST00000553317, ENST00000556936, ENST00000556996

RefSeq mRNA: 1 — MANE Select: NM_001164399 NM_001164399

CCDS: CCDS53898

Canonical transcript exons

ENST00000537690 — 20 exons

ExonStartEnd
ENSE000010947905957661959576812
ENSE000022756445950506759505315
ENSE000025385605952709559527174
ENSE000025399015955135559551436
ENSE000025473165952528259525434
ENSE000025494545954067559540746
ENSE000025503265957494359575028
ENSE000025509595953177259531910
ENSE000025629605954516359545299
ENSE000025630885953870559538840
ENSE000025637385956504759565275
ENSE000025638335956824559568380
ENSE000025641785953802359538154
ENSE000025667465957270259572813
ENSE000034905895954334459543454
ENSE000035264045956373759563859
ENSE000035557175951176059511803
ENSE000035704365952157459521676
ENSE000035879885956111959561228
ENSE000036567295951064659510808

Expression profiles

Bgee: expression breadth broad, 88 present calls, max score 80.62.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3050 / max 95.8662, expressed in 90 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1434530.165759
1434520.08825
1434540.051227

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar cortexUBERON:000212980.62gold quality
cerebellar hemisphereUBERON:000224580.55gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.48silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.28gold quality
right hemisphere of cerebellumUBERON:001489080.24gold quality
cerebellumUBERON:000203780.17gold quality
ventricular zoneUBERON:000305374.39gold quality
ganglionic eminenceUBERON:000402370.32gold quality
monocyteCL:000057667.45gold quality
right uterine tubeUBERON:000130265.48gold quality
leukocyteCL:000073864.35gold quality
testisUBERON:000047361.89gold quality
right testisUBERON:000453461.19gold quality
left testisUBERON:000453361.03gold quality
corpus callosumUBERON:000233660.90gold quality
adenohypophysisUBERON:000219657.36gold quality
pituitary glandUBERON:000000756.74gold quality
rectumUBERON:000105254.34gold quality
superior frontal gyrusUBERON:000266150.14gold quality
brainUBERON:000095549.45gold quality
colonic epitheliumUBERON:000039749.00silver quality
right frontal lobeUBERON:000281048.26gold quality
Brodmann (1909) area 9UBERON:001354047.98gold quality
primary visual cortexUBERON:000243647.12silver quality
tibial arteryUBERON:000761046.27gold quality
popliteal arteryUBERON:000225046.26gold quality
cortical plateUBERON:000534345.88gold quality
dorsolateral prefrontal cortexUBERON:000983445.78gold quality
olfactory segment of nasal mucosaUBERON:000538645.73gold quality
fallopian tubeUBERON:000388945.41gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.13

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting CCDC175, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-590-3P99.9674.346478
HSA-MIR-808799.9069.551351
HSA-MIR-153-5P99.8973.866317
HSA-MIR-451799.7669.191867
HSA-MIR-4699-3P99.7170.153142
HSA-MIR-7152-5P99.6069.332094
HSA-MIR-445299.5068.451493
HSA-MIR-6505-3P99.3467.391071
HSA-MIR-147A98.3366.40795
HSA-MIR-6880-5P98.0865.591282
HSA-MIR-3680-5P98.0666.20394
HSA-MIR-6818-5P97.5067.101167
HSA-MIR-7847-3P96.6364.58952

Literature-anchored findings (GeneRIF, showing 1)

  • The impact of modifier genes on cone-rod dystrophy heterogeneity: An explorative familial pilot study and a hypothesis on neurotransmission impairment. (PMID:36490268)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCcdc175ENSMUSG00000021086
rattus_norvegicusCcdc175ENSRNOG00000004774

Protein

Protein identifiers

Coiled-coil domain-containing protein 175P0C221 (reviewed: P0C221)

All UniProt accessions (2): P0C221, A0A0A0MTQ8

RefSeq proteins (1): NP_001157871* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR038834CCDC175Family

UniProt features (10 total): coiled-coil region 5, sequence variant 4, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0C221-F176.010.24

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 31 (showing top): chr14q23, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, H1_6_TARGET_GENES, PAX3_TARGET_GENES, ZNF618_TARGET_GENES, ZNF768_TARGET_GENES, MIR1468_3P, GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN, MIR6818_5P, GSE11924_TFH_VS_TH2_CD4_TCELL_DN, MIR6880_5P, GSE13306_RA_VS_UNTREATED_TREG_UP, GSE13306_RA_VS_UNTREATED_TCONV_DN, GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN, GSE17721_CTRL_VS_CPG_24H_BMDC_UP

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

426 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CCDC175JKAMPQ9P055643
CCDC175CLVS2Q5SYC1614
CCDC175VWC2Q2TAL6591
CCDC175CNKSR3Q6P9H4563
CCDC175RTN1Q16799522
CCDC175SORCS3Q9UPU3512
CCDC175PDE1AP54750505
CCDC175FAT2Q9NYQ8483
CCDC175PDE1CQ14123460
CCDC175LYPD6Q86Y78450
CCDC175KIF19Q2TAC6316
CCDC175GBP6Q6ZN66310
CCDC175G9CGD6G9CGD6303
CCDC175ETV1P50549288
CCDC175ECE1P42892280

IntAct

0 interactions, top by confidence:

BioGRID (8): CCDC175 (Affinity Capture-MS), CCDC175 (Affinity Capture-MS), CCDC175 (Affinity Capture-MS), CCDC175 (Affinity Capture-MS), NEB (Cross-Linking-MS (XL-MS)), CCDC175 (Cross-Linking-MS (XL-MS)), EEA1 (Cross-Linking-MS (XL-MS)), ZC3H18 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A2A2Z9, A6NC57, A8MYB1, A9JSR5, A9ZSY0, D3ZNV2, E9PVB3, O94252, P0A1K3, P0A1K4, P0C221, P0C7W6, Q01649, Q08B20, Q0VBY1, Q10006, Q10221, Q1MTQ0, Q2T9Z6, Q2TA00, Q2YDH9, Q3KPU6, Q5AI71, Q5BJE1, Q5I0J4, Q5PQJ9, Q5T0U0, Q5VUR7, Q66HB6, Q6AXT4, Q6AY08, Q6GM07, Q80X59, Q810N9, Q8BVM7, Q8BVN0, Q8CDV0, Q8IVF6, Q8IWF9, Q8N6Q1

Diamond homologs: E9PVB3, P0C221, Q2T9Z6, Q5PQJ9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

102 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance90
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3590 predictions. Top by Δscore:

VariantEffectΔscore
14:59521572:ACCCT:Adonor_gain1.0000
14:59521573:CCCTC:Cdonor_gain1.0000
14:59525283:T:TAdonor_gain1.0000
14:59538037:A:Cdonor_gain1.0000
14:59538150:CTGGT:Cacceptor_gain1.0000
14:59538155:C:CCacceptor_gain1.0000
14:59538699:TCTTA:Tdonor_loss1.0000
14:59538700:CTTA:Cdonor_loss1.0000
14:59538701:TTACC:Tdonor_loss1.0000
14:59538702:TA:Tdonor_loss1.0000
14:59538703:A:ACdonor_gain1.0000
14:59538703:A:AGdonor_loss1.0000
14:59538704:C:CCdonor_gain1.0000
14:59538704:CCT:Cdonor_gain1.0000
14:59538836:TAACA:Tacceptor_gain1.0000
14:59538837:AACA:Aacceptor_gain1.0000
14:59538838:ACA:Aacceptor_gain1.0000
14:59538839:CA:Cacceptor_gain1.0000
14:59538839:CAC:Cacceptor_gain1.0000
14:59538841:C:CCacceptor_gain1.0000
14:59538841:C:Tacceptor_loss1.0000
14:59538848:T:TCacceptor_gain1.0000
14:59543339:CATA:Cdonor_gain1.0000
14:59543342:A:ACdonor_gain1.0000
14:59543343:C:CCdonor_gain1.0000
14:59545161:A:ACdonor_gain1.0000
14:59545162:C:CCdonor_gain1.0000
14:59545166:T:Cdonor_gain1.0000
14:59561117:A:ACdonor_gain1.0000
14:59561118:C:CCdonor_gain1.0000

AlphaMissense

5283 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:59572802:T:AR85S0.959
14:59572802:T:GR85S0.959
14:59538827:A:GW457R0.958
14:59538827:A:TW457R0.958
14:59572769:G:CS96R0.951
14:59572769:G:TS96R0.951
14:59572771:T:GS96R0.951
14:59568366:C:GA124P0.948
14:59538825:C:AW457C0.946
14:59538825:C:GW457C0.946
14:59531840:A:GL565P0.943
14:59568362:C:GR125P0.942
14:59574953:A:TV78D0.941
14:59574957:C:GA77P0.941
14:59543350:A:GL426P0.938
14:59565225:A:GL181P0.938
14:59565202:C:GA189P0.932
14:59574974:A:GL71P0.930
14:59525403:C:GR625P0.928
14:59538724:C:GR491P0.924
14:59572761:A:GL99P0.922
14:59572803:C:GR85T0.922
14:59576630:A:GL49P0.921
14:59543368:A:GL420P0.919
14:59543359:A:GL423P0.916
14:59574963:C:GA75P0.912
14:59575019:A:GL56P0.912
14:59540696:A:GL445P0.908
14:59511775:A:CF709L0.902
14:59511775:A:TF709L0.902

dbSNP variants (sampled 300 via entrez): RS1000067467 (14:59524940 G>A), RS1000107456 (14:59568271 G>A), RS1000114391 (14:59555315 C>A,G), RS1000147558 (14:59506514 C>T), RS1000153871 (14:59549935 G>A), RS1000188074 (14:59518013 G>A), RS1000230113 (14:59513767 A>G), RS1000252098 (14:59517674 T>C), RS1000356468 (14:59531014 G>T), RS1000362159 (14:59561651 G>T), RS1000462929 (14:59567810 G>C), RS1000478342 (14:59561299 C>G), RS1000504883 (14:59563391 C>G), RS1000521572 (14:59568495 A>C), RS1000531839 (14:59557326 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005026_4Initial pursuit acceleration in psychotic disorders4.000000e-07
GCST010703_89Brain morphology (MOSTest)1.000000e-76

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008434initial pursuit acceleration
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
corosolic acidincreases expression1
Resveratroldecreases expression, affects cotreatment1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumdecreases expression1
Coalincreases abundance, increases expression1
Copperdecreases expression, affects cotreatment1
Potassium Dichromateincreases expression1
Smokeincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.